rolofylline has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGee, DS; Nakanishi, K; Tan, P; Vinten-Johansen, J; Zhao, ZQ | 1 |
| Dubey, RK; Forman, MB; Jackson, EK; Murray, JJ; Velasco, CE; Vitola, JV | 1 |
2 other study(ies) available for rolofylline and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phenylisopropyladenosine; Rabbits; Random Allocation; Receptors, Adrenergic, alpha-1; Theophylline; Xanthines | 1994 |
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.
Topics: Animals; Coronary Circulation; Dogs; Female; Male; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Purinergic P1 Receptor Antagonists; Xanthines | 2000 |